Amgen Seeks Dismissal Of Investor Action Over $11B Tax Bill
Amgen had no obligation to disclose specific amounts of proposed adjustments to its taxes, the company told a New York federal court as it again demanded dismissal of a proposed class...To view the full article, register now.
Already a subscriber? Click here to view full article